Consecutive Analysis of BACE1 Function on Developing and Developed Neuronal Cells

Yuji Kamikubo, Nobumasa Takasugi, Kazue Niisato, Yoshie Hashimoto, Takashi Sakurai

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The amyloid-β protein precursor (AβPP) is cleaved by a transmembrane protease termed β-site AβPP cleavage enzyme (BACE1), which is being explored as a target for therapy and prevention of Alzheimer's disease (AD). Although genetic deletion of BACE1 results in abolished amyloid pathology in AD model mice, it also results in neurodevelopmental phenotypes such as hypomyelination and synaptic loss, observed in schizophrenia and autism-like phenotype. These lines of evidence indicate that the inhibition of BACE1 causes adverse side effects during the neurodevelopmental stage. However, the effects of the inhibition of BACE1 activity on already developed neurons remain unclear. Here, we utilized hippocampal slice cultures as an ex vivo model that enabled continuous and long-term analysis for the effect of BACE1 inhibition on neuronal circuits and synapses. Temporal changes in synaptic proteins in hippocampal slices indicated acute synaptic loss, followed by synapse formation and maintenance phases. Long-term BACE1 inhibition in the neurodevelopmental stage caused the loss of synaptic proteins but failed to alter synaptic proteins in the already developed maintenance stage. These data indicate that BACE1 function on synapses is dependent on synaptic developmental stages, and our study provides a useful model to observe the long-term effect of BACE1 activity in the brain, and to evaluate adverse effects of BACE inhibitors.

Original languageEnglish
Pages (from-to)641-653
Number of pages13
JournalJournal of Alzheimer's Disease
Volume56
Issue number2
DOIs
Publication statusPublished - 2017
Externally publishedYes

Fingerprint

Synapses
Amyloid beta-Protein Precursor
Alzheimer Disease
Maintenance
Phenotype
Proteins
Autistic Disorder
Amyloid
Schizophrenia
Peptide Hydrolases
Pathology
Neurons
Inhibition (Psychology)
Brain
Enzymes
Therapeutics

Keywords

  • Alzheimer's disease
  • amyloid β
  • hippocampus
  • slice culture
  • synapse
  • β-secretase

ASJC Scopus subject areas

  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Consecutive Analysis of BACE1 Function on Developing and Developed Neuronal Cells. / Kamikubo, Yuji; Takasugi, Nobumasa; Niisato, Kazue; Hashimoto, Yoshie; Sakurai, Takashi.

In: Journal of Alzheimer's Disease, Vol. 56, No. 2, 2017, p. 641-653.

Research output: Contribution to journalArticle

Kamikubo, Yuji ; Takasugi, Nobumasa ; Niisato, Kazue ; Hashimoto, Yoshie ; Sakurai, Takashi. / Consecutive Analysis of BACE1 Function on Developing and Developed Neuronal Cells. In: Journal of Alzheimer's Disease. 2017 ; Vol. 56, No. 2. pp. 641-653.
@article{5e6d956ac05141cba73134670468920c,
title = "Consecutive Analysis of BACE1 Function on Developing and Developed Neuronal Cells",
abstract = "The amyloid-β protein precursor (AβPP) is cleaved by a transmembrane protease termed β-site AβPP cleavage enzyme (BACE1), which is being explored as a target for therapy and prevention of Alzheimer's disease (AD). Although genetic deletion of BACE1 results in abolished amyloid pathology in AD model mice, it also results in neurodevelopmental phenotypes such as hypomyelination and synaptic loss, observed in schizophrenia and autism-like phenotype. These lines of evidence indicate that the inhibition of BACE1 causes adverse side effects during the neurodevelopmental stage. However, the effects of the inhibition of BACE1 activity on already developed neurons remain unclear. Here, we utilized hippocampal slice cultures as an ex vivo model that enabled continuous and long-term analysis for the effect of BACE1 inhibition on neuronal circuits and synapses. Temporal changes in synaptic proteins in hippocampal slices indicated acute synaptic loss, followed by synapse formation and maintenance phases. Long-term BACE1 inhibition in the neurodevelopmental stage caused the loss of synaptic proteins but failed to alter synaptic proteins in the already developed maintenance stage. These data indicate that BACE1 function on synapses is dependent on synaptic developmental stages, and our study provides a useful model to observe the long-term effect of BACE1 activity in the brain, and to evaluate adverse effects of BACE inhibitors.",
keywords = "Alzheimer's disease, amyloid β, hippocampus, slice culture, synapse, β-secretase",
author = "Yuji Kamikubo and Nobumasa Takasugi and Kazue Niisato and Yoshie Hashimoto and Takashi Sakurai",
year = "2017",
doi = "10.3233/JAD-160806",
language = "English",
volume = "56",
pages = "641--653",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - Consecutive Analysis of BACE1 Function on Developing and Developed Neuronal Cells

AU - Kamikubo, Yuji

AU - Takasugi, Nobumasa

AU - Niisato, Kazue

AU - Hashimoto, Yoshie

AU - Sakurai, Takashi

PY - 2017

Y1 - 2017

N2 - The amyloid-β protein precursor (AβPP) is cleaved by a transmembrane protease termed β-site AβPP cleavage enzyme (BACE1), which is being explored as a target for therapy and prevention of Alzheimer's disease (AD). Although genetic deletion of BACE1 results in abolished amyloid pathology in AD model mice, it also results in neurodevelopmental phenotypes such as hypomyelination and synaptic loss, observed in schizophrenia and autism-like phenotype. These lines of evidence indicate that the inhibition of BACE1 causes adverse side effects during the neurodevelopmental stage. However, the effects of the inhibition of BACE1 activity on already developed neurons remain unclear. Here, we utilized hippocampal slice cultures as an ex vivo model that enabled continuous and long-term analysis for the effect of BACE1 inhibition on neuronal circuits and synapses. Temporal changes in synaptic proteins in hippocampal slices indicated acute synaptic loss, followed by synapse formation and maintenance phases. Long-term BACE1 inhibition in the neurodevelopmental stage caused the loss of synaptic proteins but failed to alter synaptic proteins in the already developed maintenance stage. These data indicate that BACE1 function on synapses is dependent on synaptic developmental stages, and our study provides a useful model to observe the long-term effect of BACE1 activity in the brain, and to evaluate adverse effects of BACE inhibitors.

AB - The amyloid-β protein precursor (AβPP) is cleaved by a transmembrane protease termed β-site AβPP cleavage enzyme (BACE1), which is being explored as a target for therapy and prevention of Alzheimer's disease (AD). Although genetic deletion of BACE1 results in abolished amyloid pathology in AD model mice, it also results in neurodevelopmental phenotypes such as hypomyelination and synaptic loss, observed in schizophrenia and autism-like phenotype. These lines of evidence indicate that the inhibition of BACE1 causes adverse side effects during the neurodevelopmental stage. However, the effects of the inhibition of BACE1 activity on already developed neurons remain unclear. Here, we utilized hippocampal slice cultures as an ex vivo model that enabled continuous and long-term analysis for the effect of BACE1 inhibition on neuronal circuits and synapses. Temporal changes in synaptic proteins in hippocampal slices indicated acute synaptic loss, followed by synapse formation and maintenance phases. Long-term BACE1 inhibition in the neurodevelopmental stage caused the loss of synaptic proteins but failed to alter synaptic proteins in the already developed maintenance stage. These data indicate that BACE1 function on synapses is dependent on synaptic developmental stages, and our study provides a useful model to observe the long-term effect of BACE1 activity in the brain, and to evaluate adverse effects of BACE inhibitors.

KW - Alzheimer's disease

KW - amyloid β

KW - hippocampus

KW - slice culture

KW - synapse

KW - β-secretase

UR - http://www.scopus.com/inward/record.url?scp=85011339261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011339261&partnerID=8YFLogxK

U2 - 10.3233/JAD-160806

DO - 10.3233/JAD-160806

M3 - Article

VL - 56

SP - 641

EP - 653

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 2

ER -